Samsung Medison is garnering attention from the global medical community with its ultrasound diagnostic solutions across the women’s life stage from fetal stage to menopause.

At the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG 2025) in Cancún, Mexico on September 14, Samsung Medison will showcase its comprehensive women’s health solution under the theme “From Challenges to Solutions: Experience the Innovation.”

From Fetal Stage to Menopause Ultrasound Solution Demonstration Tailored to Women’s Life Stages

The highlight of upgraded HERA Z20, to be unveiled at ISUOG, features diagnostics tailored to every life stage of women. It supports healthcare professionals in managing women’s health comprehensively with a single equipment, enabling dedicated management of women’s health across all stages, from adolescent gynecological conditions and fertility to maternity and aging.

Newly added PelvicAssist and three types of reporting features propose diagnostic support innovation for the women and healthcare professionals whom have difficulties due to the gynecological conditions. PelvicAssist automatically analyzes multiple pelvic regions and measures the levator hiatus area, providing the 3D image.

Due to the complexity of anatomical structures, considerable time is required to precisely assess and report lesion location, size, shape and degree of invasion. In response, Samsung Medison has unveiled tailored diagnostic reporting solution based on standardized clinical guidelines.

Fibroid 2D, which simplifies the reporting procedure for uterine fibroid by applying The International Federation of Gynecology and Obstetrics (FIGO) guideline. IDEA and IETA highly enhanced diagnostic workflow efficiency by supporting scan procedures and reporting based on guidelines for endometriosis and endometrial tumor evaluation, respectively.

The ultra-compact probe Mini ER7, developed to minimize patient discomfort during gynecological examinations by offering 63% smaller head compared to conventional probes, it is expected to significantly reduce the burden for adolescent and elderly patients.

Ultrasound Solutions for High-risk Pregnancy Care and Enhanced Clinical Efficiency

With maternal age on the rise, high-risk pregnancies are becoming common. In response to this social challenge, Samsung Medison has integrated Ophthalmic Artery feature to detect systemic vasoconstriction in early stages — a key factor of pre-eclampsia.

As the Ophthalmic Artery branches directly from the internal carotid artery, it allows for indirect monitoring of cerebral blood flow, which is difficult to access, enabling the early detection of potential cardiovascular disease. The expanded HeartAssist further supports maternal health by real-time monitoring of cardiovascular conditions during pregnancy.

Healthcare professional’s work efficiency is at the center of Samsung Medison’s innovation. Live ViewAssist automatically extracts up to 39 ultrasound cross-sectional images, provides automated annotations and measurement results for key parameters throughout the pregnancy cycle, and reduce diagnostic time.

The integrated QualityCheck feature automatically evaluates the quality of extracted images during fetal diagnosis, supporting consistency of diagnostic accuracy.

Jihyun Kim, Head of the CX group at Samsung Medison said: “The Upgraded HERA 20 is more than just an equipment enhancement but it’s a total solution designed to support women’s health across all life stages. By combining AI technology with the healthcare professional’s clinical experience, we aim to enhance diagnostic accuracy and reduce burdens, ultimately driving meaningful change in the healthcare field.”

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, participates the 34^th annual academic conference of ISUOG World Congress 2024 (International Society of Ultrasound in Obstetrics & Gynecology) held in Budapest, Hungary from 15 to 18 September.

Samsung Medison showcases HERA Z20, a new premium ultrasound system for OB&GYN, in ISUOG regarded as the most important academic conference in the world in the field of OB&GYN ultrasound.

HERA Z20 further enhanced the cutting edge AI diagnostic assistance features to improve health of women and fetuses. The Live ViewAssist provides a real-time diagnosis location, is newly integrated to HERA Z20. The Live ViewAssist reduces time required for measurement and increases accuracy by automatically classifying cross sections and providing measurement results for entire quarter of OB&GYN.

Live Q-scan and A-Focus features have been newly added to HERA Z20 to provide a more uniform image and sharper image quality. The Live Q-scan reduces noises that appear during the ultrasound examination in real-time, and A-Focus provides clearer images in every scanning depth. Crystal Architecture, Samsung Healthcare proprietary ultrasound imaging technology, also uses the upgraded second generation engine to increase clarity of image.

HERA Z20 enhances user convenience through My HERA going beyond the AI diagnostic assist feature. My HERA as a feature enabling user to build personalized ultrasound system by setting the diagnostic setting values for each user type in advance, can be customized depending on user preference.

Additionally, the EzStructure and EzFlow features provide convenient, optimal imaging settings for the anatomy to be examined with a single touch of a button. The main monitor and touch panel have freely adjustable angles and are ergonomically tailored for user convenience.

Samsung Medison plans to conduct a live scan of the HERA Z20 onsite to showcase the real-time AI diagnostic assist and reporting features that are faster and stronger than before.

In ISUOG, Samsung Medison also introduces theSUITE website for the first time along with HERA Z20 where educational contents of Samsung ultrasound system are complied. The new website membership registration event will be held to celebrate theSUITE launch in ISUOG. Samsung Medison will utilize theSUITE to improve access to the information of each product feature for domestic and overseas medical professionals and secure global bidding competitiveness.

Meanwhile, Samsung Medison pursues the realization of eco-friendly values based on IT technology of Samsung from the product development stage by minimizing energy consumption through analysis of customer’s product usage pattern.

HERA Z20 has reduced the product volume minimizing the number of components by incorporating circuit integration technology mainly utilized for mobile devices, etc. In addition, the packaging and cushioning materials are the replaced with 100% recycled paper by optimizing the packing design to withstand heavy load on paper, and eco-friendly recycled plastic material is utilized for the system body.

Samsung Medison designated part of exhibition hall as ‘eco-friendly zone’ and shares own energy policy at the booth that built using environmental friendly materials.

Kyutae Yoo, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison said “We are committed to doing our best to further increase global market share through launch of a new premium ultrasound system for OB&GYN, new educational website and synergy with Sonio which is equipped with exceptional AI reporting software,” and “We will leap forward as a global leader in the medical equipment industry by improving product performance and sustainability through technology innovation.”

▲ The ISUOG World Congress will be held in Seoul, Korea from October 16 to 19

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, will be showcasing its AI-based diagnostic solutions at ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) World Congress 2023 held in Seoul, South Korea from October 16 to 19.

As one of the most important academic societies in the field of obstetric and gynecologic ultrasound, ISUOG organizes annual congresses worldwide to share the latest technology and research findings. This year’s event, held for the first time in Seoul, will be attended by nearly 2,000 obstetricians and gynecologists from 126 countries.

Samsung Medison, a main sponsor of the event, will showcase Samsung’s AI diagnostic technology through the display of its premium ultrasound systems “HERA W10 Elite” and “V8,” diagnostic solution demonstrations and a symposium.

▲ Samsung Medison’s HERA W10 Elite(left) and V8 will be exhibited at ISUOG 2023

HERA W10 Elite is a premium ultrasound system equipped with a 27-inch OLED monitor, which exhibits less brightness variation across viewing angles than conventional LCD monitors. Its probe delivers superior resolution, allowing users to view high-contrast ultrasound images from various angles without compromising image quality.

At the conference, Samsung Medison will showcase AI-based diagnostic assistant solutions, including HeartAssist, which categorizes and provides measurement results for fetal heart diagnosis with a simple press of a button; and UterineAssist, which automatically measures the size and shape of the uterus helping to accurately examine and diagnose the uterus.

In addition, Samsung Medison will present AI-automated measurement functions such as BiometryAssist and ViewAssist, which measure and automatically annotate fetal growth indicators by extending the items previously measured only in the 2nd trimester (14-27 weeks) to the 1st trimester (1-13 weeks) in accordance with the newly revised ISUOG guidelines in February 2023.

“Using the BiometryAssist feature, fetal weight can be measured with professional accuracy up to 48 hours before delivery, and the measurement time can be dramatically reduced,” said Professor Mar Gil of Torrejón University Hospital, Spain, in an abstract of the study available for publication at the conference.

At the conference, Samsung Medison will also introduce an upgraded version of “5D CNS (Central Nervous System)+,” a convenient feature for fetal brain examination.

A positive reception is anticipated at the conference due to its automatic provision of nine essential cross-sections of the fetal brain, including the coronal and sagittal planes and six measurements necessary for diagnosis – head circumference and diameter, with high accuracy.

Other features such as SonoSync, which specializes in remote consulting and training, and S-Hub, an IT solution for hospital resource management, will be on display to medical professionals from around the world.

Samsung Medison will hold symposia on “Obstetrics” and “Gynecology” on October 17 and 18, respectively, to present research findings on the clinical utility of features that help diagnose the heart and brain of a fetus and endometriosis.

During the “Fetal Therapy and Telesonography” session in the “Obstetrics” symposium, Dr. Ruben Quintero from The Fetal Institute in the United States will present a case where SonoSync, a real-time ultrasound image-sharing solution with remote control ability, saved the life of a mother and her newborn in a case of misdiagnosed fetal distress.

In the “Gynecology” symposium, Professor Tom Bourne from Imperial College, U.K., will present his research on ovarian tumors using CrystalVue and MV-Flow features.

“Samsung is continuously developing AI technologies that improve diagnostic efficiency so that doctors can focus more on patient care,” said Jinyong Lee, Head of the AI Vision Group at Samsung Medison. “We are continually striving to develop technologies that can be utilized in the field of obstetrics and gynecology to contribute to improving maternal and fetal health.”

The conference, which is held for the first time in South Korea, is also the first offline event since the end of the COVID-19 pandemic. Samsung Medison is participating as the main sponsor and engaging in various academic activities, including the Samsung-ISUOG webinars and the Pre-Congress.

▲ ISUOG Industry Webinar schedule

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit www.samsunghealthcare.com.

During this congress, Samsung will be showcasing the clinical values and efficiencies of the Artificial Intelligence (AI)-based diagnostic solutions through various scientific programs.

Samsung’s symposium will be held on September 18^th at 12:35 p.m. This event will also run online under the theme of “Samsung’s Advanced AI and Remote Diagnosis Solutions.” Prof. Julien Stirnemann (Necker Hospital, France) will deliver research results on the clinical values of two AI diagnostic solutions: BiometryAssist which measures the growth and condition of a fetus and HeartAssist which improves workflow when diagnosing a fetal heart.

Professor Antonia Testa (Scientific Director of the Center for Ultrasound in Gynecological Oncology “Class Ultrasound” of the Agostino Gemelli University Hospital, Rome, Italy) will be demonstrating her experience with SonoSync, a real-time ultrasound image-sharing solution during Samsung’s Symposium. She will be presenting the simplicity and benefits of image sharing as a second opinion by remotely accessing a HERA W10 system at Gemelli Hospital, Rome from the ISUOG venue in London.

“This will be a live demonstration of a patient scan, voice communication with a sonographer, and remote measurements executed in London. This advancement in ultrasound environment using SonoSync brings telesonography into reality,” said Professor Antonia Testa. “I believe Samsung’s forward-thinking technologies and advanced developments in ultrasound in recent years are quite impressive.”

In addition, Samsung will be hosting four onsite Hospitality Suite programs with lectures and live demonstrations for customers to experience high performance diagnostic solutions such as MV-Flow which is used to visualize the slow flow of microvascular structures and the existence of micro-blood-flow.

The onsite scientific programs, Samsung will display online webinars at six times during the congress through ISUOG’s virtual platform. More details on Samsung’s scientific programs can be found on the ISUOG website and the Samsung’s Healthcare website (www.samsunghealthcare.com).

Samsung will also showcase its premium ultrasound system for obstetrics and gynecology known as HERA W10 and V8 which systems includes Intelligent Assist (AI diagnostic solutions), as well as V7, high-end ultrasound systems that can be used in various medical specialties and also with premium AI diagnostic solutions.

As far as the name, the “V” in “V7” stands for “Versatile,” meaning that this system can be used in various medical fields such as obstetrics, gynecology, radiology, orthopedics, cardiology and more. The V7 hosts features and solutions seen on premium ultrasound systems.

※ The diagnostic solutions provided with V8 and V7 are the same, but there are some differences in their image resolution.

Kyu Tae Yoo, Senior Vice President, Head of Sales & Marketing Team of Samsung Medison stated “This is a very meaningful time for us as we share the clinical values of our ultrasound AI-based diagnostic tools and features in collaboration with so many prominent medical professionals. We will continuously proceed forward introducing diagnostic solutions for the medical professionals and patients.”

For more information on Samsung’s Healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Exhibition products at ISUOG 2022 (from left — V7, HERA W10, V8)

SonoSync — Solution to overcome spatial constraints when performing ultrasound exams

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

“Since the launch of the ‘Intelligent Assist’ solution in 2020, we have been actively listening to the needs of our customers and have reflected the needs of the market into our enhanced AI-based image processing technologies and diagnostic assistance functions,” said Won-Chul Bang, Vice President, Head of Customer Experience Team at Samsung Medison. “We will actively introduce various ultrasound diagnosis solutions to meet customers’ needs in the future preemptively.”

Samsung is launching its enhanced ‘Intelligent Assist’ software in its premium ultrasound device, HERA W10, and will be presenting its clinical values for “Improving Accuracy and Efficiency” for fetal anomaly detection using its AI solutions during the online symposium on October 17^th.

‘Intelligent Assist’ solution includes ‘Biometry Solution’ for assessment of the fetal growth and ‘Fetal Heart Solution’ for the assessment of the fetal heart.

‘Biometry Solution’ recognizes images such as the fetal head, abdomen, lower extremities and others and measures the fetal growth and development while the ‘Fetal Heart Solution’ recognizes the view of the fetal heart, annotates the images and measures the necessary fetal heart structures for a thorough fetal heart anomaly assessments.

During the symposium, Aris Papageorghiou, Clinical Research Director of the Maternal and Perinatal Health Institute at Oxford UK and the professor in obstetrics and fetal medicine at St George’s University Hospitals UK, will be introducing his clinical experiences with Samsung’s ‘Intelligent Assist’ solutions.

Hye-Sung Won, professor of the Department of Obstetrics and Gynecology at Asan Medical Center, Korea, will introduce the MPI+ that semi-automatically measure LV MPI and RV MPI to analyze the fetal heart function. She will also be presenting her findings of the feasibility and reliability of ‘Fetal Heart Solution’ in automatically providing complex fetal heart view image classifications and fetal heart structural measurements.

In addition, Samsung will be introducing its high-end versatile ultrasound device ‘V8’, first released on September 30^th, at the virtual exhibition hall during ISUOG 2021.

‘V8’ will include some of the enhanced solutions that are dedicated to the premium ultrasound system such as MV-Flow, a novel alternative to power Doppler for visualizing the slow flow of micro-vascularized structures, and LumiFlow, three-dimensional visualization of blood flow which helps the user understand the structure of small vessels intuitively. ‘V8’ will also include some of the ‘Intelligent Assist’ solutions to cater to the needs of the larger busy hospitals.

For more information on Samsung’s healthcare division, its subsidiaries and products, please visit https://www.samsunghealthcare.com.

The image delineates that the fetal head is automatically recognized and measured along with the fetal growth when ‘Biometry Solution’ is executed.

The feature automatically recognizes and annotates the anatomy of the fetal heart and displays measured values when the ‘Fetal Heart Solution’ is executed.

About Samsung Medison
Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

Examinations for women with high risk pregnancy, early diagnosis of fetal abnormalities, and automatic measurement solutions in ultrasound for delivery—quality healthcare solutions enabled by Samsung Medison—have been acknowledged and noted in the medical profession.

The devices will be showcased on an online platform prepared for the virtual event, which will feature webinars, virtual exhibitions and chat tools. Samsung Medison will display its new HERA series of ultrasound devices (HERA W10, HERA I10, HERA W9) featuring its new advanced technologies and solutions. The various Intelligent Assist solutions, elaborating on the details will be presented in a video format.

The solutions which expand across the full spectrum of diagnostic functions and capabilities include the following:

• BiometryAssist – Measures the fetal growth index quickly and confidently with the view that has been acquired semi-automatically.
• HeartAssist¹ – Helps to measure and provide a suitable guideline view for an early finding of congenital heart abnormalities for the fetus before it is born, utilizing deep learning.
• LaborAssist – Allows easy discovery of changes over the measured time, and provides demo video and animation images for clear explanation and communication of the delivery process to the mothers.

BiometryAssist and LaborAssist are expected to simplify the user’s workflow by not only reducing simple repetitive manual tasks, but also increasing measurement accuracy and providing consistent measurements.

These two features have been developed by incorporating the Intel Distribution of the OpenVINO toolkit into Samsung’s diagnostic algorithm. By using the OpenVINO toolkit, powered by Intel processors, data processing moves at a speed 4.7 times faster than equipment without the OpenVINO enhancements.²

“Our Intelligent Assist solutions enhance patient comfort and clinician’s convenience, reduce scan time, improve diagnosis accuracy, and increase system throughput. Samsung will continue to develop the next-generation ultrasound solutions in collaboration with Intel for the ongoing development of Intelligent Assist solutions,” announced Won-Chul Bang, Vice President of Health & Medical Equipment Business, Samsung Electronics and Samsung Medison.

The event also includes three rounds of webinars, during which world prominent OB/GYN specialists will share the clinical results of various diagnostic tools, including MV-Flow, LumiFlow and CrystalVue, which are available in the HERA series.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

Intel, the Intel logo, and OpenVINO are trademarks of Intel Corporation or its subsidiaries.

The screen that automatically recognizes and annotates the heart on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

The screen that automatically recognizes the heart and displays measured values on the ‘Fetal Cardiac Ultrasound’ screen when HeartAssist is executed.

¹ 510(k) pending at FDA

² Source: Internal Samsung testing.
System configuration: Intel Core i3-4100Q CPU @ 2.4 GHz, 8 GB memory; OS: 64-bit Windows 10.
Inference time without OpenVINO enhancements was 480 milliseconds. Inference time with OpenVINO enhancements was 85 milliseconds.

Samsung showcases premium new ultrasound systems ‘HERA W10’ and ‘HERA I10’ at ISUOG World Congress 2018

HERA is a new premium platform which stands for Hyper-aperture Enhanced Reconstruction Architecture, incorporating Samsung’s new Crystal Architecture to provide advanced technology and capabilities with a new level of image quality. Samsung’s new platform combines Crystal Architecture with an advanced transducer technology called S-Vue. It allows an 11-fold increase in processing power and 10 times the data transfer speed of Samsung’s previous system. It is expected to facilitate the examination of high-risk pregnancies and early diagnosis of abnormal fetus conditions.

“Samsung is proud to introduce a new premium ultrasound system HERA W10 and a form factor innovation ultrasound HERA I10, as well as solutions that greatly improve the efficiency of hospitals,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Samsung will continue to provide the best solutions possible and bring meaningful changes in the healthcare industry.”

New features for Samsung’s HERA W10 ultrasound system offer clinicians an optimized workflow and more information to overcome challenges, including:

Outstanding Image Quality

• Crystal Architecture – Offers a superior image with single crystal probe technology S-Vue, a new beamforming technology CrystalBeam and an advanced post-processing engine CrystalLive.
• ShadowHDR – Provides a shadow suppressed image, especially applicable to highly attenuated regions such as fetal head and spine.
• HQ-Vision – Allows users get high resolution images to detect clinically important details.

New Samsung Exclusive Technologies

• MV-Flow – Offers a detailed view of blood flow in relation to the surrounding tissues or pathology with an enhanced spatial and temporal resolution.
• LumiFlow – Provides a three-dimensional visualization of continuous and volumic vascular image.

Seamless Workflow

• Wide Control Panel – Adopted rotatable control panel with a top-notch swivel mechanism. Allows moving range of 550mm from left to right and 219mm from top to bottom.
• Touch Customization – Allows users to easily change the position of the button on the touchscreen for each mode and feature.

In addition to HERA W10, Samsung is unveiling a prototype of HERA I10, which shares the same platform as HERA W10, but with a completely new ergonomic redesign. HERA I10 is a next-generation chair-type ultrasound system with a design that is entirely different from the industry norm that meets the unique needs of Ob/Gyn professionals. HERA I10 provides a comfortable experience for both the doctor and the patient by addressing the discomfort caused by the spacing and the position of the clinicians and eliminating the need for the patient to shift the body, as it automatically adjusts for proper positioning. It also reduces the force required to move the control panel back and forth and the resistance force on the wrist.

A new ultrasound solution SonoSync will also be introduced, which allows healthcare professionals to see real-time ultrasound scanning images in remote places¹. SonoSync provides two-way communications through voice chatting and marking, improving accessibility. It can be installed on various devices such as smartphones, laptops and desktop PCs, allowing multilocation real-time training and education among healthcare professionals. Its Multiview feature also increases productivity by viewing multiple image scans in one screen.

For more information on Samsung’s healthcare division, its subsidiaries and products please visit https://www.samsunghealthcare.com.

¹SonoSync may not be used for diagnostic purposes at all times. Its availability may vary in different countries, according to regulatory approvals.

About Samsung Medison

Samsung Medison is a global leading medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being of people’s lives, the company is committed to create a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, is hosting a number of seminars at the 27th World Congress of the International Society of Ultrasound in Obstetrics & Gynecology (ISUOG) in Vienna. Through 13 sessions at Samsung’s Satellite Symposium, leading medical professionals are publicizing the clinical benefits of Samsung’s ultrasound imaging solutions for women’s health.

Professor Lami Yeo, M.D., from the Department of Obstetrics and Gynecology at the Wayne State University School of Medicine in Detroit, U.S., presented research on the diagnostic performance of Fetal Intelligent Navigation Echocardiography (5D Heart) which showed a sensitivity of 98%, specificity of 93%, and accuracy of 95% for the prenatal detection of congenital heart disease*.  She also explained that 5D Heart offers a rapid and simple solution to screen for and diagnose congenital heart disease by generating nine standard fetal echocardiography views in a single template display.

Additionally, novel research conducted on color Doppler Fetal Intelligent Navigation Echocardiography (5D Heart Color) will be published in the October 2017 issue of the scientific journal Ultrasound in Obstetrics & Gynecology (UOG), which will also feature on its front cover, the prenatal diagnosis of congenital heart disease using 5D Heart color.

In addition recently developed diagnostic tools such as E-Cervix, Crystal Vue and IOTA-ADNEX from Samsung’s Crystal Clear Cycle, the lifelong healthcare solution for women, are also being presented throughout the congress.

Samsung also displayed prototypes of ultrasound system with new ergonomics and stress-relief transducers, as well as cloud-based IT solution at a private room for selectively invited key opinion leaders. Visitors to the room shared feedbacks that the next-generation product meets the needs of professionals and patients with a form that is entirely unlike the norm. Some also showed positive response to the new IT solution designed to provide efficiency for doctor’s demanding tasks, and that they look forward to its commercial release.

“I believe Samsung’s proactive technological developments in ultrasound in recent years are providing quite significant clinical value to the field. Samsung has been releasing machines for users at all levels of expertise,” said Dr. Andrew Ngu, former President of the ISUOG. “Seeing Samsung’s vision for design innovations that enhance user workflow and efficiency, it is not difficult to expect Samsung to play a pivotal role as a game changer for the future ahead.”

For additional information, [click here].

* Congenital heart disease is the most common organ-specific birth defect, and is also the leading cause of infant mortality from congenital malformations. The performance of conventional two-dimensional ultrasound of the fetal heart is time-consuming, requires considerable expertise and skill, and therefore is highly operator dependent. As a result, not all fetal cardiac views required for the accurate prenatal detection of congenital heart disease may be routinely obtained.

Samsung Medison is showcasing its latest imaging and diagnostic solutions at ISUOG (International Society of Ultrasound in Obstetrics and Gynecology)’s 25th World Congress on Ultrasound in Obstetrics and Gynecology, being held at the Palais des congrès de Montréal in Canada from October 11 to 14. Samsung Medison, an affiliate of Samsung Electronics, is a manufacturer of diagnostic ultrasound machinery. Samsung is displaying the upgraded packages of premium ultrasound system WS80A with Elite, featuring various research functions and new visualization technology along with academic seminars on clinical values of key features.

“At this congress, the WS80A with Elite is presenting a new level of imaging and diagnostic solutions in OB/GYN, which bring users a step closer to see and diagnose the fetus with clarity and confidence,” said Soo-in Cho, CEO of Samsung Medison, adding, “Samsung continues to develop technologies that enhance user’s experience in women’s health and collaborate with professionals at the International Society of Ultrasound in Obstetrics and Gynecology for academic breakthroughs.”

The key upgrades of the WS80A with Elite include:

Semi-automated Diagnosis for Research

• 5D Heart Color — Generates nine standard fetal echocardiography views simultaneously in a single template with blood flow dynamics of fetal heart by using STIC (Spatio-Temporal Image Correlation) volume datasets.
• 5D Limb Vol. — Semi-automatically provides volume measurements of upper arm or thigh of a fetus which can be used to calculate an accurate estimation of fetal weight and nutritional status.
• 5D CNS+ — Provides axial, sagittal, and coronal views of fetal brain in nine planes by automatic measurement of biometry, following the international screening guidelines by ISUOG for fetal brain.

More Clarity in Assessing Fetus

• Crystal Vue — An advanced volume rendering technology which enables users to assess detailed information of internal and external structures of fetus by an intuitive 3D/4D visualization, providing increased diagnostic confidence.

“We have been impressed by the images we have obtained both in early pregnancy and when we have examined ovarian masses with Crystal Vue. We seem to be getting novel information,” said Professor Tom Bourne, research team leader in the Department of Surgery & Cancer within the Faculty of Medicine at Imperial College in the U.K. “We are currently carrying out clinical trials to see how this new technique impacts on diagnostic performance.”

About Samsung Medison

Samsung Medison, an affiliate of Samsung Electronics, is a global medical equipment company founded in 1985. With a mission to bring health and well-being to people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. Samsung Medison has commercialized the Live 3D technology in 2001 and since being part of Samsung Electronics in 2011, it is integrating IT, image processing, semiconductor and communication technologies into ultrasound devices for efficient and confidence diagnosis.

For more information, please visit www.samsungmedison.com.

To learn more about Samsung’s global medical equipment business, please visit samsung.com/global/business/healthcare/.